top of page


About Renatus Animal Health

Renatus Animal Health division was established to use our science to support the valuable bond between pets and their owners. Our goal is to provide veterinarians and pet owners with innovative cholesterol modulators that can help pets with cholesterol-driven diseases live healthier, longer lives.

Pipeline overview

Pipeline Overview

Kidney disease


Tox study
Feline chronic kidney disease
Canine chronic kidney disease

Chronic kidney disease

Chronic kidney disease

The overall prevalence of CKD in cats is about 2% to 4%, which increases to 30% to 40% in cats over the age of 10. CKD affects about 0.5% to 1.5% of dogs, which increases with age as well. Simple calculation shows that more than 6.6 million owned cats and 4.7 million owned dogs would have CKD.

CKD is a progressive and irreversible disease, as in humans, so early diagnosis and proper treatment initiation is crucial to help them receive the full advantages of treatment and live a better quality of life.

As disease progresses, the kidney function and life expectancy decreases

CKD life expectancy.png

The International Renal Interest Society (IRIS) has classified CKD in cats and dogs into four major stages based on blood creatinine concentration. Furthermore, they can be substaged based on proteinuria and blood pressure.

Stages of CKD in cats and dogs

CKD stage 3.png
bottom of page